Abstract
Large-scale randomized comparison of drug-eluting stents (DES) based on durable polymer versus biodegradable polymer technology is currently insufficient in patients with acute coronary syndrome (ACS). The present study aimed to prove the noninferiority of the durable polymer DES (DP-DES) compared with the biodegradable polymer DES (BP-DES) in such patients. The HOST-REDUCE-POLYTECH-ACS (Harmonizing Optimal Strategy for Treatment of Coronary Artery Diseases-Comparison of Reduction of Prasugrel Dose or Polymer Technology in ACS Patients) trial is an investigator-initiated, randomized, open-label, adjudicator-blinded, multicenter, noninferiority trial comparing the efficacy and safety of DP-DES and BP-DES in patients with ACS. The primary end point was a patient-oriented composite outcome (a composite of all-cause death, nonfatal myocardial infarction, and any repeat revascularization) at 12 months. The key secondary end point was device-oriented composite outcome (a composite of cardiac death, target-vessel myocardial infarction, or target lesion revascularization) at 12 months. A total of 3413 patients were randomized to receive the DP-DES (1713 patients) and BP-DES (1700 patients). At 12 months, patient-oriented composite outc...Continue Reading
References
Jan 22, 2011·Journal of the American College of Cardiology·Gaku NakazawaRenu Virmani
Jan 1, 2013·Journal of the American College of Cardiology·Kyung Woo ParkHyo-Soo Kim
Feb 5, 2013·Lancet·Pieter Cornelis SmitsMartin van der Ent
May 21, 2013·Journal of the American College of Cardiology·Masahiro NatsuakiUNKNOWN NEXT Investigators
Sep 21, 2013·JACC. Cardiovascular Interventions·Kyung Woo ParkHyo-Soo Kim
Apr 29, 2014·Journal of the American College of Cardiology·Masataka NakanoRenu Virmani
Sep 6, 2014·Lancet·Thomas PilgrimStephan Windecker
Aug 22, 2015·JACC. Cardiovascular Interventions·Fumiyuki OtsukaMichael Joner
Sep 17, 2015·Trials·Joo Myung LeeHyo-Soo Kim
Mar 17, 2016·Circulation. Cardiovascular Interventions·Islam Y ElgendyAnthony A Bavry
Nov 4, 2016·Lancet·Clemens von BirgelenMarije M Löwik
Nov 11, 2017·Arteriosclerosis, Thrombosis, and Vascular Biology·Jaryl NgNicolas Foin
Apr 6, 2018·EuroIntervention : Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·Sho ToriiAloke V Finn
May 23, 2018·European Heart Journal·Giulio GuagliumiDavide Capodanno
Sep 27, 2018·Lancet·Clemens von BirgelenMarlies M Kok
Jan 1, 2019·Thrombosis and Haemostasis·Jeehoon KangHyo-Soo Kim
May 13, 2019·European Heart Journal·Sergio BuccheriGiovanna Sarno
Jul 28, 2019·Nature Reviews. Cardiology·Sho ToriiAloke V Finn
Sep 7, 2019·Lancet·Juan F IglesiasThomas Pilgrim
Citations
Jan 16, 2021·European Heart Journal·Fernando AlfonsoJavier Escaned
Mar 16, 2021·Circulation·Robert A Byrne, Colm G Hanratty
Nov 19, 2021·European Journal of Epidemiology·Maarten J G Leening, Karim D Mahmoud